Skip to main content
. 2024 Jun 20;16(6):e62775. doi: 10.7759/cureus.62775

Figure 1. CONSORT flow diagram of the study.

Figure 1

Group HF-S/V, patients undergoing treatment with sacubitril/valsartan; Group HF-CT, patients receiving conventional therapy

CONSORT, Consolidated Standards of Reporting Trials; HF, heart failure